RCEL · NASDAQ
AVITA Medical (RCEL) Stock Price & Fundamentals
AVITA Medical (RCEL) closed at $526.63 on Oct 9, 2026, up 1.25% from the previous close of $520.14.
Share price, past year
1Y +26.48%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $526.63 |
| Sep 30, 2026 | $534.80 |
| Aug 31, 2026 | $510.68 |
| Jul 31, 2026 | $511.20 |
| Jun 30, 2026 | $489.96 |
| May 29, 2026 | $487.88 |
| Apr 30, 2026 | $480.32 |
| Mar 31, 2026 | $487.97 |
| Feb 27, 2026 | $478.00 |
| Jan 30, 2026 | $494.78 |
| Dec 31, 2025 | $483.24 |
| Nov 28, 2025 | $458.53 |
| Oct 31, 2025 | $432.86 |
Key statistics
- Market cap
- $16.29B
- P/E (TTM)
- —
- EPS (TTM)
- −$1.43
- Revenue (TTM)
- $75.63M
- Net income (TTM)
- −$43.08M
- Shares outstanding
- 30.9M
- Dividend yield
- —
- 52-week range
- $415.02 – $542.26
AVITA Medical's market cap is $16.29B, based on a share price of $526.63 and 30.9M shares outstanding as of Jun 30, 2026.
Financials
AVITA Medical reported revenue of $71.61M for fiscal 2025, up 11.45% from fiscal 2024.
AVITA Medical reported a net loss of $48.59M in fiscal 2025.
Fiscal 2025 revenue was the highest in the 8 years shown.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2025ended Dec 31, 2025 | $71.61M | +11.5% | −$48.59M | −67.9% | −$1.74 | −$32.21M |
| FY2024ended Dec 31, 2024 | $64.25M | +28.1% | −$61.85M | −96.3% | −$2.39 | −$58.07M |
| FY2023ended Dec 31, 2023 | $50.14M | +45.7% | −$35.38M | −70.6% | −$1.40 | −$39.39M |
| FY2022ended Dec 31, 2022 | $34.42M | +17.8% | −$26.67M | −77.5% | $1.07 | −$19.54M |
| FY2021ended Jun 30, 2021 | $29.23M | +105.0% | −$26.58M | −90.9% | $1.17 | −$26.80M |
| FY2020ended Jun 30, 2020 | $14.26M | +160.6% | −$42.03M | −294.7% | $2.07 | −$23.34M |
| FY2019ended Jun 30, 2019 | $5.47M | +489.2% | −$25.10M | −458.6% | $1.56 | −$20.27M |
| FY2018ended Jun 30, 2018 | $929.00K | — | −$12.74M | −1,370.8% | $1.37 | −$13.33M |
| Quarter | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| Q2 FY2026ended Jun 30, 2026 | $21.70M | −$7.66M | −$0.25 |
| Q1 FY2026ended Mar 31, 2026 | $19.25M | −$10.61M | −$0.35 |
| Q4 FY2025ended Dec 31, 2025 | $17.62M | −$11.62M | −$0.37 |
| Q3 FY2025ended Sep 30, 2025 | $17.06M | −$13.19M | −$0.46 |
| Q2 FY2025ended Jun 30, 2025 | $18.42M | −$9.92M | −$0.38 |
| Q1 FY2025ended Mar 31, 2025 | $18.51M | −$13.86M | −$0.53 |
| Q4 FY2024ended Dec 31, 2024 | $18.41M | −$11.59M | −$0.44 |
| Q3 FY2024ended Sep 30, 2024 | $19.55M | −$16.21M | −$0.62 |
Company profile
- Name
- AVITA Medical, Inc.
- Ticker
- RCEL
- Exchange
- NASDAQ
- Industry (SEC SIC)
- Surgical & Medical Instruments & Apparatus
- Headquarters
- 28159 Avenue Stanford, Suite 220, Valencia, CA 91355
- Incorporated in
- DE
- Fiscal year ends
- December
- SEC CIK
- 0001762303
Recent SEC filings
- Aug 11, 2026
- Aug 6, 2026
- Aug 6, 2026
- Jun 8, 2026
- Jun 4, 2026
- May 14, 2026
- May 14, 2026
- May 1, 2026
Frequently asked questions
What is AVITA Medical's stock price?
AVITA Medical (RCEL) closed at $526.63 on Oct 9, 2026, up 1.25% from the previous close of $520.14.
What is AVITA Medical's market cap?
AVITA Medical's market cap is $16.29B, based on a share price of $526.63 and 30.9M shares outstanding as of Jun 30, 2026.
How much revenue does AVITA Medical make?
AVITA Medical reported revenue of $71.61M for fiscal 2025, up 11.45% from fiscal 2024.
Does AVITA Medical pay a dividend?
AVITA Medical's recent filings report no dividends declared over the last four quarters.
Sources and methodology
Fundamentals come from AVITA Medical, Inc.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures